Drug Pipeline

migalastat HCl 150 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
3
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06904261 A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and… Fabry Disease Recruiting
NCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in… Fabry Disease Active, Not Recruiting
NCT04020055 A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal… Fabry Disease Active, Not Recruiting
Phase 2
NCT05747534 AT1001 for the Treatment of Long COVID Long COVID Active, Not Recruiting
Not specified
NCT06906367 A Study of Patients With Fabry Disease (US Specific) Fabry Disease Recruiting
Sponsors Running migalastat HCl 150 mg Trials
Get alerts when migalastat HCl 150 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free